BRAF and melanoma: Melanoma mutations are common in BRAF (50%), NRAS (13.25%), MEK1 (6%), and less commonly KIT (2.6%), CTNNB1 (2%–3%), GNA11 (2%), or GNAQ (1%), highlighting the importance of controlled MAPK signaling for melanocyte homeostasis (9).